PRESS RELEASE published on 08/27/2025 at 06:47, 9 months 30 days ago Aroundtown announces H1 2025 results demonstrating a strong balance sheet, paving the way for opportunistic growth Aroundtown announces strong H1 2025 results with stable net rental income and adjusted EBITDA. Balance sheet shows decreased LTV to 40% and successful bond issuances, aiming for growth opportunities Growth Opportunities Balance Sheet Aroundtown Bond Issuances H1 2025 Results
PRESS RELEASE published on 08/27/2025 at 06:45, 9 months 30 days ago Aroundtown announces H1 2025 results demonstrating a strong balance sheet, paving the way for opportunistic growth Aroundtown announces strong H1 2025 results with stable net rental income and decreased LTV, paving the way for growth. CFO transition announced Balance Sheet CFO Transition Aroundtown H1 2025 Results Opportunistic Growth
BRIEF published on 06/02/2025 at 12:31, 1 year ago Aroundtown SA Maintains Strong Performance amidst Market Challenges Real Estate Aroundtown SA Investment Rating Equity Research Q1 Performance
BRIEF published on 06/02/2025 at 12:31, 1 year ago Aroundtown SA maintient de solides performances malgré les défis du marché Immobilier Aroundtown SA Notation D'investissement Recherche Sur Les Actions Performances Du Premier Trimestre
PRESS RELEASE published on 06/02/2025 at 12:26, 1 year ago Original-Research: Aroundtown SA (von First Berlin Equity Research GmbH): Kaufen First Berlin Equity Research updates Aroundtown SA analysis, reiterates BUY rating with EUR 4.00 price target. Q1 shows good operational performance, solid rental growth, and positive revaluations First Berlin Equity Research BUY Rating Aroundtown SA Q1 Performance EUR 4.00 Price Target
BRIEF published on 05/28/2025 at 07:00, 1 year ago Aroundtown SA Reports Strong Q1 2025 Performance Financial Results Bond Issuance Credit Rating Aroundtown Q1 2025
BRIEF published on 05/28/2025 at 07:00, 1 year ago Aroundtown SA annonce de solides performances au premier trimestre 2025 Résultats Financiers Emission D'obligations Cote De Crédit Autour De La Ville T1 2025
BRIEF published on 05/28/2025 at 06:57, 1 year ago Aroundtown Reports Stable Q1 2025 Results Amid Market Volatility Financial Results Debt Management Net Rental Income Property Revaluation Aroundtown Q1 2025
BRIEF published on 05/28/2025 at 06:57, 1 year ago Aroundtown annonce des résultats stables au premier trimestre 2025 malgré la volatilité du marché Résultats Financiers Gestion De La Dette Revenu Locatif Net Réévaluation De La Propriété Aroundtown T1 2025
PRESS RELEASE published on 05/28/2025 at 06:55, 1 year ago Aroundtown SA announces Q1 2025 results with strong operations Aroundtown SA announces strong Q1 2025 results with higher net profit and positive property revaluation despite S&P credit rating downgrade. Company successfully completes €750 million bond issuance Aroundtown SA Net Profit Bond Issuance Property Revaluation Q1 2025 Results
Published on 06/26/2026 at 14:05, 2 hours 37 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 2 hours 42 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 3 hours 42 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 3 hours 57 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 15:30, 1 hour 11 minutes ago JMGO Extends Special Savings Beyond Prime Day with N3 Ultimate at Its Best Price Since Launch
Published on 06/26/2026 at 15:23, 1 hour 18 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/26/2026 at 15:23, 1 hour 19 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 06/26/2026 at 15:22, 1 hour 19 minutes ago Form 8.3 - The Vanguard Group, Inc.: Senior plc
Published on 06/26/2026 at 07:00, 9 hours 42 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 9 hours 42 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
